The Comparative Study of the Therapeutic Effects and Mechanism of Baicalin, Baicalein, and Their Combination on Ulcerative Colitis Rat
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Baicalin and baicalein are the primary effective substance of scutellaria baicalensis. It has been reported that baicalin and baicalein protect rats from ulcerative colitis(UC). Baicalin and baicalein have differential pharmacological of activities anti-inflammation, anti-oxidation, lipid-lowering and liver-protection in vivo and in vitro. It has been reported that UC has a great relationship with TH17/Treg regulation. The current study’s aims to determine the pharmacodynamic differences and potential mechanisms of baicalin, baicalein and their combinations[YSR(Young scutellaria baicalensis ratio of baicalin and baicalein=4:1), WSR(Withered scutellaria baicalensis ratio of baicalin and baicalein=1:1)] in the treatment of UC. We established UC model rats by composite factors [high-sugar and high-fat diet, high-temperature and high-humidity environment(HTHE) with Escherichia coli infection] to compare the therapeutic Effects and mechanisms of baicalin, baicalein and their combination, and then analyzed their metabolism in target tissue. As a result, the study shows that baicalin, baicalein, YSR, and WSR all have significantly therapeutic effects on UC, and have significantly different in the treatment of UC in the clinical symptoms and signs, such as fever, organ/body weight(BW) ratio, serum inflammatory cytokines levels, blood biochemistry and histopathology changes of main organs. We found that baicalin and baicalein have more potency in treating UC, and their combination provides a more comprehensive treatment, along with the higher of baicalin proportion, YSR generated the best effective treatment, which conforms to the traditional concept of optimization young Scutellaria baicalensis(Tiaoqin in Chinese) in treating large intestine disease. LC-MS/MS results show the conversion of baicalin and baicalein(in separation or combination) into six metabolites, baicalin, wogonoside, melaloside A, baicalein, Wogonin, and lamellar A e.g.. The levels of the six metabolites were significantly different in the large intestine, small intestine, and lung, but not in the serum. These results indicate that baicalin and baicalein should be used more accurately in specific diseases, especially baicalin or high content of baicalin in Scutellaria baicalensis should be preferred in treatment of UC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Unravelling the pathogenesis of inflammatory bowel disease
Xavier, R. J., & Podolsky, D. K. (2007) · Nature · doi:10.1038/nature06005 · Cited by 4,364 · cited 1×
“These large ulcers continue to destroy the intestinal mucosa causing tissue damage, and can even result in the formation of cancerous lesions (Xavier and Podolsky, 2007).”
BackgroundAfzali, B., Lombardi, G., Lechler, R. I., & Lord, G. M. (2007) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2007.03356.x · Cited by 762 · cited 1×
“Normally, the differentiation of TH17 helper cells is induced by IL-6 and transforming growth factor (TGF)-β, and is followed by the release of cytokines such as IL-1β, IL-6, and tumor necrosis factor (TNF)-α against extracellular bacteria and mold immune responses (Afzali et al., 2007).”
BackgroundThe Role of IL-17 and related cytokines in inflammatory autoimmune diseases
Kuwabara, T., Ishikawa, F., Kondo, M., & Kakiuchi, T. (2017) · Mediators of Inflammation · doi:10.1155/2017/3908061 · Cited by 519
Cited by
Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients
Su, H.-X., Yao, S., Zhao, W.-F., Li, M.-J., Liu, J., Shang, W.-J., Xie, H., Ke, C.-Q., Hu, H.-C., Gao, M.-N., et al. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0483-6 · Cited by 456
Yu, C., Wang, D., Yang, Z., & Wang, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23136939 · Cited by 162
Song, L., Zhu, S., Liu, C., Zhang, Q., & Liang, X. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.13703 · Cited by 51
Zhao, M., Wang, P., Sun, X., Yang, D., Zhang, S., Meng, X., Zhang, M., & Gao, X. (2023) · Molecules · doi:10.3390/molecules28227562 · Cited by 14
Metadata
- Authors
- Liang, S., Deng, X., Lei, L., Zheng, Y., Ai, J., Chen, L., Xiong, H., Mei, Z., Cheng, Y.-C., & Ren, Y.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2019-12-13
- Volume
- 10
- Pages
- 1466-1466
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W3008659397
- Cited by
- 95
- References
- 3
- FWCI
- 6.01
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.